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The type-1 diabetes autoantigen ICA512/IA-2/RPTPN is a receptor protein tyrosine 29 
phosphatase of the insulin secretory granules, which regulates the size of granule stores, 30 
possibly via cleavage/signaling of its cytosolic tail. The role of its extracellular region, 31 
instead, remains unknown. Structural studies indicated that  β2- or β4-strands in the 32 
mature ectodomain (ME ICA512) form dimers in vitro. Here we show that ME ICA512 33 
prompts proICA512 dimerization in the endoplasmic reticulum. Perturbation of ME 34 
ICA512 β2-strand N-glycosylation upon S508A replacement allows for proICA512 35 
dimerization, O-glycosylation, targeting to granules and conversion, which are instead 36 
precluded upon G553D replacement in the ME ICA512 β4-strand. S508A/G553D or 37 
N506A/G553D double mutants dimerize, but remain in the endoplasmic reticulum. 38 
Removal of the N-terminal fragment (ICA512-NTF) preceding ME ICA512 allows 39 
instead an ICA512-ΔNTF G553D mutant to exit the endoplasmic reticulum and ICA512-40 
ΔNTF is constitutively delivered to the cell surface. The signal for SG sorting is located 41 
within the NTF RESP18-homology domain (RESP18-HD), whereas soluble NTF is 42 
retained in the endoplasmic reticulum. Hence, we propose that the ME ICA512 β2-strand 43 
fosters proICA512 dimerization until NTF prevents N506 glycosylation. Removal of this 44 
constraint allows for proICA512 β4-strand induced dimerization, exit from the 45 
endoplasmic reticulum, O-glycosylation and RESP18-HD-mediated targeting to granules. 46 
 47 
48 




Receptor protein tyrosine phosphatases (RPTPs) form a large family of transmembrane 51 
proteins, which counteract protein tyrosine kinases, and are therefore involved in many 52 
signaling pathways. Dimerization of RPTPs is regarded as a main mechanism to regulate 53 
their constitutive intracellular phosphatase activity. The contribution of extracellular, 54 
transmembrane and cytoplasmic PTP regions to dimerization varies among different 55 
RPTPs (1-4). 56 
The extracellular domains of RPTPs can promote the receptor dimerization in several 57 
ways. As for receptor protein tyrosine kinases, RPTP oligomerization and clustering can 58 
be induced upon heterophilic binding to extracellular ligands. RPTPs for which such 59 
mechanism has been demonstrated include the type I RPTP CD45/RPTPC, the type IIa 60 
RPTPσ, the type III RPTPβ and the type V RPTPζ (5). In the case of CD45 and RPTPβ 61 
changes in their glycosylation pattern, including O-glycosylation, were shown to 62 
modulate their binding to galectin-1, conceivably increasing clustering and affecting 63 
phosphatase activity (6, 7). Homophilic interactions among ectodomains of RPTPs in the 64 
same or apposing cells, as it is the case for the type IIb RPTPμ and RPTPκ or the type IV 65 
RPTPα, likely represent another mechanism for inducing receptor oligomerization and 66 
regulating phosphatase activity (8-10). 67 
The type VII RPTPs ICA512/IA-2/PTPRN and its homologue phogrin/IA-68 
2β/PTPRN2 are ‘pseudophosphatases’ with a large ectodomain followed by a 69 
transmembrane region and a single catalytically inactive PTP domain (11, 12). They are 70 
mainly expressed in neuropeptidergic neurons and peptide-secreting endocrine cells, 71 
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including insulin producing pancreatic βcells, where they are enriched in secretory 72 
granules (SGs) (13, 14). Upon expression in Escherichia coli the transmembrane regions 73 
of phogrin and ICA512 showed only weak or no ability to interact (2). On the other hand, 74 
in transfected fibroblasts the cytosolic juxtamembrane and PTP domains of ICA512 and 75 
phogrin were shown to form homodimers as well as heterodimers with each other and 76 
with the PTP domains of other conventional RPTPs, possibly inhibiting their phosphatase 77 
activity (15). In insulinoma cells, homodimerization of the ICA512 PTP domain was 78 
found to disrupt the interaction of the latter with the cortical actin cytoskeleton, thereby 79 
affecting insulin SG dynamics and exocytosis (16). 80 
Recent structural studies on the membrane-proximal, recombinant mature, 81 
ectodomain of ICA512 (ME ICA512/IA-2), which results from cleavage of proICA512 82 
by prohormone convertases during SG maturation (13, 17), show that this region readily 83 
adopts various dimeric assemblies both in the protein crystals and in solution (18, 19). In 84 
contrast, the corresponding recombinant mature ectodomain of phogrin, despite its 85 
structural similarity to ICA512 (20, 21), was found to fold as a monomer in solution (20, 86 
21). In this study, therefore, we investigated the ability of ME ICA512 to induce receptor 87 
homodimerization in insulin-producing cells. 88 
89 
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MATERIALS AND METHODS 90 
 91 
Generation of ICA512 constructs and site-directed mutagenesis. pEGFP-N1 92 
constructs encoding full length human ICA512 (amino acids 1-979), ICA512 N-terminal 93 
fragment (NTF, amino acids 35-446), ICA512 ΔNTF (amino acids 449-979), ICA512 94 
Regulated endocrine-specific protein 18 homology domain (RESP18-HD, amino acids 95 
35-131) or ME (amino acids 449-575) were fused at their C-termini to green fluorescent 96 
protein (GFP) or a hemagglutinin (HA) epitope tag. These constructs included either the 97 
native signal peptide or that of CD33, while an 11-mer linker was placed between ME 98 
ICA512 and GFP. Conventional cloning strategies were also used to generate ICA512-99 
NTF or a secretory GFP by inclusion of the CD33 signal peptide at the N-terminus. Site-100 
directed mutagenesis, using these constructs as template, was performed with the 101 
QuikChangeTM kit (Stratagene). All constructs and mutations were verified by 102 
sequencing. 103 
Antibodies against ICA512-NTF, ME ICA512, and ICA512 CT. Mouse 104 
monoclonal antibodies directed against a recombinant fusion protein between GST and 105 
amino acids 389-575 (anti-ectodomain) or amino acids 935-974 (anti-ICA512 106 
cytoplasmic tail; CT) of human ICA512 were generated in the Antibody Facility at the 107 
Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG, Dresden, 108 
Germany). The ectodomain antibodies were further selected for recognition of an epitope 109 
within amino acids 389-446 of the NTF (anti-ICA512 NTF ab) or amino acids 449-575 of 110 
ME ICA512 (anti-ME ICA512 ab) using a MesoScale Discovery platform and by 111 
Western blotting against ICA512-NTF-GFP, ICA512-GFP ΔNTF and GST.  112 
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Culture and transfection of insulinoma INS-1 cells. Rat INS-1 cells were grown in 113 
RPMI 1640 medium as described (22). Cells were split every 4-days, plated onto 114 
coverslips on 35 mm dishes (Costar® 3516) and transfected 3 days after with plasmid-115 
DNA diluted into CytoporationR medium using Cyto Pulse electroporator (Cyto Pulse 116 
Sciences, Inc.). Four days after transfection, cells were pre-incubated for 1 hour in resting 117 
buffer (5 mM KCl, 120 mM NaCl, 24 mM NaHCO3, 1 mM MgCl2, 2 mM CaCl2, 1 118 
mg/ml ovalbumin, 5 mM HEPES pH 7.5) and then either kept at rest or in stimulation 119 
buffer [25 mM glucose (high glucose, HG) and 55 mM KCl (high K+, HK) in 70 mM 120 
NaCl, 24 mM NaHCO3, 1 mM MgCl2, 2 mM CaCl2, 1 mg/ml ovalbumin, 5 mM HEPES 121 
pH 7.5] for additional 2 hours. In some instances, 30 μM Calpeptin or MG-115 122 
(Calbiochem) was added to the stimulation buffer. After 2 hours of incubation, cells were 123 
washed twice with ice-cold PBS and harvested in ice-cold lysis buffer [(20 mM Tris-Cl 124 
pH 8.0, 140 mM NaCl, 1 mM EDTA, 1 mM Triton X-100 and 1% protease inhibitor 125 
cocktail (Sigma P8340)]. Cell lysates were centrifuged at 4°C 12,000 rpm for 5 min in an 126 
Eppendorf 5415C centrifuge. The pre-cleared soluble protein fraction was separated from 127 
the pellet and prepared in SDS-PAGE sample buffer for Western blotting analysis. 128 
Immunoprecipitation (IP). Equal amount of cell lysates were mixed with 20 μl 129 
(1/10 vol/vol) Protein G Sepharose beads (GE Healthcare), and incubated on a rotating 130 
wheel at 4°C for 30 min to pre-clear the lysates of the IgG bound protein fraction. The 131 
lysates were centrifuged at 2,000 rpm for 3 min in the Eppendorf centrifuge and the pellet 132 
of beads removed. Goat anti-GFP antibodies (MPI-CBG, Dresden, Germany) or IgG 133 
from goat serum (Sigma I5256), 1:100-dilution, respectively, were then incubated with 134 
the pre-cleared lysates overnight prior to the addition of 20 μl (1/10 vol/vol) Protein G 135 
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Sepharose beads. The lysates were centrifuged at 2,000 rpm for 3 min and the soluble 136 
fraction was removed. The beads were washed twice with PBS, centrifuged as above and 137 
re-suspended in SDS-PAGE sample buffer for Western blotting analysis. 138 
Enzymatic de-glycosylation assays. INS-1 cells transfected for expression of 139 
different ICA512 variants, or mouse or human islet cells, were incubated in resting or 140 
stimulation buffer for 2 hours. Cells were lysed as above and incubated in denaturation 141 
buffer (New England Biolabs) at 95°C for 5 min. The denatured samples of the cell 142 
lysates were then incubated with PNGaseF, Endoglycosidase H or O-glycosidases, endo-143 
α-N-acetylgalatosaminidase and neuramidase in 1x reaction buffer (New England 144 
Biolabs) at 37°C for 3 hours. Glycosylated fetuin from fetal calf serum (Sigma F2379) 145 
was used as a control to confirm the performance of glycosidases. Non- and enzyme-146 
treated cell lysates were prepared in SDS-PAGE sample buffer for Western blotting 147 
analysis. 148 
Western blotting. Cell lysates and IPs in SDS-PAGE sample buffer were heated to 149 
95°C for 5 min, and then subjected to SDS-PAGE and Western blotting. The following 150 
primary antibodies were employed: mouse monoclonal anti-GFP antibody (Clontech 151 
#632381); mouse anti-ICA512 antibody, HM-1 (23); mouse anti-γ-tubulin antibody 152 
(Sigma T6557) and rabbit anti-HA antibody (Abcam ab9110). Primary antibodies were 153 
detected with goat anti-mouse or anti-rabbit HRP-conjugated IgGs (Bio-Rad) followed by 154 
addition of substrates for chemiluminescence (Thermo Scientific, Pierce Biotechnology) 155 
and a LAS-3000 Imaging System (Fuji). Black dividing lines indicates cutting of the 156 
same or different Western blots or their groupings. 157 
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Immunostaining and confocal microscopy. INS-1 cells transfected for the 158 
expression of different ICA512 variants and grown on coverslips on 35 mm dishes for 4 159 
days post-transfection were incubated in resting or stimulation buffer as described above, 160 
then rinsed 3x in PBS and fixed with 4% paraformaldehyde. After aldehyde quenching 161 
and permeabilization (200 mM glycine, 0.1% Triton X-100 in PBS) for 20 min, cells 162 
were incubated in blocking buffer (0.2% Gelatin, 0.5% albumin in PBS) for 1 hour, and 163 
thereafter in blocking buffer with guinea pig anti-insulin antibody (Abcam ab7842) or 164 
rabbit anti-calnexin antibody (Sigma C4731) at 4°C overnight. Next, cells were washed 165 
5x with PBS, and then incubated in blocking buffer with goat anti-guinea pig or anti-166 
rabbit AlexaFluor568-conjugated IgGs (Molecular Probes) for 2 hours at room 167 
temperature. After additional washing 5x with PBS, immunolabeled coverslips were 168 
mounted onto slides with MowiolTM.  169 
INS-1 live cell staining with the ER tracker red dye (glibenclamide BODIPY®TR; 170 
Molecular Probes) was done according to the manufacturer’s protocol. ICA512 mature 171 
ectodomain or cytosolic domain specific antibodies (see above), the anti-ME ICA512 172 
antibody or the anti-ICA512 CT antibody was incubated with living INS-1 cells to assess 173 
ICA512 extracellular domain exposure at the cell surface. Images of labeled cells were 174 
acquired with an Olympus FluoView-1000 laser scanning confocal microscope equipped 175 
with a 60x PlanoApo OLSM lens (NA=1.10). 176 
Cell sorting. Four days post-transfection with ICA512-GFP, ICA512-GFP G553D or 177 
ICA512-GFP N506A/N524A cells were detached by trypsin digestion and re-suspended 178 
in 1x PBS, 25 mM HEPES (pH 7.0), 1 mM EDTA and 1% albumin. The cell suspension 179 
was filtered through cell-strained cap in 5 ml round-bottom Falcon® tubes (Corning 180 
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352235) prior to sorting for GFP expression with a Becton Dickinson BD FACS Aria II. 181 
Sorted cells expressing the ICA512-GFP variants were cultured in 24 mm culture dishes 182 
(Costar® 3513) in RPMI 1640 medium.   183 
Insulin gene expression, contents and secretion. After two days in culture, the total 184 
RNA of 1x105 cells sorted for the expression of each ICA512-GFP variant was purified 185 
with Qiagen RNeasy Kit and used as RNA template for the First-Strand cDNA synthesis 186 
with SuperScriptTM II reverse transcriptase (Invitrogen) and oligo (dT) primer. Levels of 187 
insulin mRNA were analysed by Quantitative real-time PCR with the qPCR GoTaq kit 188 
(Promega) and an MX4000 Thermocycler (Stratagene). β-actin mRNA was amplified in 189 
parallel for normalization of the insulin mRNA levels in the individual samples. 190 
Alternatively, 3x105 ICA512-GFP+ sorted cells were switched to resting buffer for pre-191 
incubation for 1 hour and then to resting or stimulation buffer for additional 2 hours 192 
before being harvested for analyses for proinsulin/ insulin content and insulin secretion in 193 
static conditions with Rat/Mouse Proinsulin/ Rat Insulin ELISA (Mercodia).  194 
Statistical analysis. All data are representative of three or more independent 195 
experiments, with the exception of the analysis in human islets, which was performed 196 
two times. Statistical significance was assessed with student’s T-test or ANOVA. 197 
 198 
199 




ProICA512 dimerizes in INS-1 cells. ME ICA512 encompasses amino acids 449-575 of 202 
human ICA512 (Fig. 1A). The X-ray structure of recombinant ME ICA512 (Fig. 1B) (18) 203 
encompassing amino acids 468-558 revealed that this region displays a ferredoxin-like 204 
fold related to the SEA (sea urchin sperm protein, enterokinase, agrin) domain, which is 205 
known to promote oligodimerization (24-28). Accordingly, both crystallized (18) and 206 
soluble (19) ME ICA512 form dimers resulting from the antiparallel pairing of β2-β2 or 207 
β4-β4 strands (Fig. 1B) (19). 208 
To verify the occurrence of ICA512 dimers in insulin-producing cells, full-length 209 
ICA512 constructs differentially tagged at their C-termini with GFP (ICA512-GFP) or a 210 
HA epitope (ICA512-HA) (Fig. 2A) were transiently expressed alone or together in rat 211 
insulinoma INS-1 cells. Consistent with previous findings (29, 30), the mature 212 
transmembrane fragments (TMF) of ICA512-GFP (ICA512-TMF-GFP; ~100 kDa) and 213 
ICA512-HA (ICA512-TMF-HA; ~75 kDa) were the major ICA512 species detected in 214 
cell lysates of resting (R) INS-1 cells (Fig. 2A). In cells stimulated (S) with 25 mM 215 
glucose with or without 55 mM KCl, the respective proICA512 species became the most 216 
prominent species, while the levels of the corresponding ICA512-TMF, which undergo 217 
calpain mediated cleavage upon SG exocytosis (29, 30), were drastically reduced. 218 
Stimulation with 55 mM KCl alone, which prompts SG exocytosis, reduced also the 219 
levels of ICA512-TMF, but barely up-regulated those of proICA512. The detection of 220 
multiple proICA512 species reflects the different degree of glycosylation of the protein 221 
during its maturation along the secretory pathway prior to cleavage and conversion into 222 
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ICA512-TMF. Notably, in cells stimulated with 55 mM KCl alone, the major proICA512 223 
form migrated faster than the proICA512 species detected in cells concomitantly exposed 224 
to high glucose. This discrepancy conceivably reflects differences in the efficiency of 225 
proICA512 N-glycosylation in the endoplasmic reticulum (ER) depending on the glucose 226 
levels.   227 
ProICA512-HA and ICA512-TMF-HA were readily detectable, albeit at lower levels 228 
when co-expressed with ICA512-GFP (Fig. 2B). Immunoprecipitation with anti-GFP 229 
antibodies led to the recovery of ICA512-TMF-GFP or proICA512-GFP from resting or 230 
stimulated cells, respectively (Fig. 2C, top panel). Co-immunoprecipitation of 231 
proICA512-HA, but not of ICA512-TMF-HA, suggests that proICA512, but not ICA512-232 
TMF form dimers (Fig. 2C, bottom panel). Neither ICA512-GFP nor ICA512-HA co-233 
immunoprecipitated with control IgGs.  234 
ME ICA512 mediates the dimerization of proICA512 in INS-1 cells. Previous 235 
studies in vitro and in transfected INS-1 cells indicated that the intracellular PTP domain 236 
of ICA512 can dimerize (15, 16). To verify whether ME ICA512 could account for 237 
proICA512 dimerization independently of the cytoplasmic domain, INS-1 cells were 238 
transfected with ICA512-HA either alone or in combination with soluble ME ICA512-239 
GFP (Fig. 2D, left panel). The slowest electrophoretic species of ME ICA512 was 240 
upregulated in stimulated cells and migrated at the expected size of ca. 50 kDa, taking 241 
into account also its N-glycosylation. The fastest migrating species corresponds instead to 242 
the non-glycosylated form of ME ICA512-GFP (see also below, Fig. 5D). 243 
Immunoprecipitation of ME ICA512-GFP led to the specific recovery of proICA512-HA 244 
from both resting and stimulated cells (Fig. 2D, right panel). Hence, consistent with in 245 
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vitro structural and biochemical analyses (18, 19), ME ICA512 is sufficient to induce the 246 
dimerization of proICA512 in INS-1 cells. 247 
Lack of N-glycosylation or perturbation of the β2-β2 association interface of ME 248 
ICA512 do not preclude SG sorting and conversion of ICA512. Electrophoretic 249 
mobility shift of ICA512 upon digestion with PNGaseF indicated that the protein is N-250 
glycosylated (17, see also below Fig. 4C and 8D). ICA512 contains only two consensus 251 
sites for N-glycosylation at N506 and N524, both within ME ICA512 (Fig. 1A and 1B). 252 
N506 is located in the β2-strand (Fig. 1B), a critical structural element for β2-β2 253 
dimerization (19). The consensus sequence for N506 glycosylation includes S508, which 254 
was shown to mediate β2-β2 dimerization of ME ICA512 in vitro (19). N524 is instead 255 
remote from the identified dimerization interfaces (Fig. 1B). 256 
To verify the glycosylation of both N506 and N524, INS-1 cells were independently 257 
transfected with the single mutants ICA512-GFP N506A, ICA512-GFP S508A and 258 
ICA512-GFP N524A, or with the double mutant ICA512-GFP N506A/N524A. ICA512-259 
TMF of all ICA512-GFP mutants, as detected with the anti-GFP or the anti-ICA512 HM-260 
1 antibody, displayed a faster electrophoretic mobility than wild type ICA512 in resting 261 
cells (Fig. 3A). A similar behavior was observed for the corresponding proICA512-GFP 262 
species in resting and stimulated cells (Fig. 3A and 3B). Thus, both N506 and N524 are 263 
glycosylated. The expression of proICA512-GFP N506A/N524A was significantly higher 264 
than that of ICA512-GFP or single N-glycosylation ICA512-GFP mutants (Fig. 3C), 265 
conceivably due to its delayed folding, traffic and conversion. Lack of N-glycosylation, 266 
however, did not prevent the sorting of ICA512-GFP N506A/N524A into SGs, as 267 
indicated by its co-localization with insulin at the cell periphery of INS-1 cells similar to 268 
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ICA512-GFP (Fig. 3D). Notably, ICA512-GFP S508A, in which the β2-β2 dimerization 269 
should be perturbed (19), was also sorted into SGs (Fig. 3D).  270 
The total levels of insulin mRNA in ICA512-GFP N506A/N524A+ sorted cells was 271 
not significantly changed compared to ICA512-GFP+ sorted cells (Fig. 3E). Likewise, in 272 
ICA512-GFP N506A/N524A+ sorted cells the proinsulin (Fig. 3F) and insulin (Fig. 3G) 273 
content as well as the fractional stimulated insulin secretion (Fig. 3H) were not 274 
significantly reduced compared to ICA512-GFP+ sorted cells.  275 
Perturbation of the ME ICA512 β4-β4 association interface precludes SG sorting 276 
and conversion of ICA512. The replacement of G553, which sterically and 277 
electrostatically hinders β4-β4 dimerization (19), differently from the replacement of 278 
N506 or S508 in the β2-β2 interface, profoundly altered the maturation and stability of 279 
ICA512. Specifically, the expression of ICA512-TMF-GFP G553D was dramatically 280 
reduced (Fig. 4A and 4B, lane 4). This was also the case upon cell treatment with the 281 
proteasome inhibitor MG-115 (Fig. 4A, lane 6) or calpeptin (Fig. 4B lane 6), which 282 
prevents the calpain-mediated cleavage of ICA512-TMF and thus its disappearance (Fig. 283 
4B, lane 3). These observations suggested that the G553D replacement prevents the 284 
conversion of proICA512-GFP into ICA512-TMF-GFP. Conversely, expression of 285 
ICA512-GFP G553D correlated with the enrichment of proteolytic fragments, mostly in 286 
resting cells (Fig. 4A and 4B, lanes 1 and 4), but also in stimulated cells treated with MG-287 
115 (Fig. 4A, lanes 3 and 6) or calpeptin (Fig. 4B, lanes 3 and 6). Notably, proICA512-288 
GFP G553D appeared as a single band with electrophoretic mobility comparable to the 289 
fastest migrating species of proICA512-GFP (Fig. 4A and 4B, lane 2 vs. 5). Sensitivity to 290 
PNGaseF treatment indicated, that this phenotype is not attributed to lack of N-291 
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glycosylation (Fig. 4C). Analysis by confocal microscopy further indicated that ICA512-292 
GFP G553D (Fig. 4D left panel), unlike ICA512-GFP and ICA512-GFP S508A (Fig. 293 
3D), did not co-localize with insulin (Fig. 4D, left panel), but was dispersed throughout 294 
the cytoplasm with a reticular pattern resembling that of ER tracker red dye (Fig. 4D, 295 
right panel). These data suggested that ICA512-GFP G553D is retained within the ER.  296 
In ICA512-GFP G553D+ sorted cells, similar to ICA512-GFP N506A/N524A+ sorted 297 
cells (see above, Fig. 3), the total levels of insulin mRNA was not changed (Fig. 4E). The 298 
proinsulin (Fig. 4F) and insulin content (Fig. 4G) as well as the fractional stimulated 299 
insulin release (Fig. 4H) were also not significantly changed relative to ICA512-GFP+ 300 
sorted cells.  301 
ICA512 is O-glycosylated. ME ICA512 possesses a SEA domain fold, which is 302 
present in some mucins and other membrane proteins. SEA domain containing proteins 303 
are commonly extensively O-glycosylated nearby this domain, possibly to hinder its 304 
proteolysis (25, 27, 28). We wondered therefore, whether ICA512 is also O-glycosylated 305 
and whether this modification, which mainly occurs in the Golgi, would be affected by 306 
the G553D replacement. 307 
O-glycosidase treatment increased the electrophoretic mobility of the O-glycosylated 308 
control protein fetuin (Fig. 5A), as well as that of ICA512-TMF-GFP in extracts of 309 
resting cells (Fig. 5B, lane 1 vs. 2). De-O-glycosylation of lysates from stimulated cells 310 
led to the almost complete disappearance of the slowest migrating species of proICA512-311 
GFP (Fig. 5B, lane 3 vs. 4). A comparable mobility shift of ICA512-TMF was observed 312 
upon O-glycosidase treatment of lysates of mouse and human islets (Fig. 5C), thus 313 
indicating that this modification, similar to N-glycosylation (17), occurs also in non-314 
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transformed ICA512 expressing tissues. ProICA512-GFP N506A (Fig. 5B, lane 5 vs. 6 315 
and lane 7 vs. 8) and proICA512-GFP S508A (Fig. 5B, lane 9 vs. 10 and lane 11 vs. 12), 316 
as well as the corresponding ICA512-TMF forms (Fig. 5B, lane 5 vs. 6 and lane 9 vs. 10), 317 
were also O-glycosidase sensitive. Conversely, the single proICA512-GFP G553D 318 
species was O-glycosidase insensitive (Fig. 5B, lane 15 vs. 16), consistent with its 319 
retention in the ER (Fig. 4D). 320 
Relevance of the NTF domain for O-glycosylation and export of proICA512 321 
from ER. Soluble ME ICA512-GFP, ME ICA512-GFP S508A and ME ICA512-GFP 322 
G553D (Fig. 5D, lanes 1, 5 and 9) were reduced to a single band upon treatment with N-323 
glycosidases, Endoglycosidase H (Fig. 5D, lanes 2, 6 and 10) or PNGaseF (Fig. 5D, lanes 324 
3, 7 and 11), but were insensitive to O-glycosidases (Fig. 5D, lanes 4, 8 and 12). Thus, 325 
multiple ME ICA512-GFP species result from N-glycosylation alone. However, the 326 
Endoglycosidase H sensitivity of all these ME ICA512 variants further indicated these 327 
retain the high-mannose structure N-oligosaccharide chains, i.e. they are not exported 328 
from the ER. Indeed, confocal microscopy indicated that ME ICA512-GFP or its G553D 329 
variant was found to accumulate in the ER (Fig. 5E), concurrent with the lack of O-330 
glycosylation. 331 
Sequence analysis of ICA512 with NetOGlyc 3.1 (31) pointed to serines and 332 
threonines clustered within amino acid residues 400-440, i.e. in the NTF domain (13, 17), 333 
preceding ME ICA512, as the most likely sites for O-glycosylation (Fig. 1A). 334 
Nonetheless, the deletion mutant ICA512-GFP ΔNTF, which lacks amino acid residues 335 
35-448 (Fig. 1A), i.e. the entire NTF domain, as well as the corresponding ICA512-GFP 336 
ΔNTF S508A and ICA512-GFP ΔNTF G553D mutants, were both PNGaseF (Fig. 5F, 337 
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lanes 3, 7 and 11) and O-glycosidase (Fig. 5F, lanes 4, 8 and 12) sensitive. Notably, 338 
ICA512-GFP ΔNTF and ICA512-GFP ΔNTF G553D displayed comparably slower 339 
electrophoretic mobility than ICA512-GFP ΔNTF S508A, suggesting their similar 340 
glycosylation at N506 and N524. Moreover, ICA512-GFP ΔNTF G553D, similar to all 341 
other constructs lacking NTF, was Endoglycosidase H resistant (Fig. 5F, lanes 2, 6 and 342 
10) and unlike ICA512-GFP G553D did not undergo extensive proteolysis. Evidence that 343 
proICA512 mutants lacking NTF domain can fold and exit from the ER, even if the ME 344 
ICA512 β4-β4 dimerization interface is perturbed suggests that this region contains 345 
information for retention of unfolded proICA512 in the ER. 346 
ICA512-NTF is required for targeting of proICA512 to the SGs. To further verify 347 
the progression of ICA512-GFP ΔNTF along the secretory pathway, we imaged its 348 
localization in non-permeabilized resting (Fig. 6A and 6B) or stimulated (Fig. 6C) INS-1 349 
cells kept at 4°C to block endocytosis. Both ICA512-GFP and ICA512-GFP ΔNTF, as 350 
detected with their GFP fluorescence, appeared enriched at the cell periphery (Fig. 6A, 351 
6B and 6C). However, labeling with a novel mouse anti-ME ICA512 antibody revealed 352 
that ICA512-GFP ΔNTF, unlike ICA512-GFP, was exposed at the cell surface even in 353 
resting conditions (Fig. 6A). As expected, the concomitant control labeling of resting 354 
cells for insulin, which like ICA512-GFP should be mainly confined to SGs and not be 355 
exposed at the surface, was negative (Fig. 6A). Surface labeling with a mouse anti-356 
ICA512 CT antibody was also negative (Fig. 6B). Conversely, the anti-ME ICA512 357 
antibody labeled the cell surface of both ICA512-GFP and ICA512-GFP ΔNTF 358 
stimulated cells, albeit more prominently in the case of the latter cells (Fig. 6C). Thus, 359 
ICA512-GFP ΔNTF, unlike ICA512-GFP, is constitutively targeted to the cell surface.     360 
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Immunoblotting with anti-GFP (Fig. 6D) or anti-ME ICA512 (Fig. 6E) antibodies 361 
indicated that unlike ICA512-GFP (Fig. 6D and 6E, lanes 1 vs. 2), ICA512-GFP ΔNTF 362 
(Fig. 6D and 6E, lanes 3 vs. 4) is not susceptible to Ca2+/calpain-dependent cleavage 363 
upon stimulation of INS-1 cells. Hence, the NTF domain is not only required to retain 364 
unfolded proICA512 in the ER, but also for targeting the latter to SGs, thus enabling the 365 
cleavage of ICA512-TMF upon granule exocytosis (29, 30). 366 
The RESP18 homology domain targets proICA512 to SGs. The most N-terminal 367 
portion of ICA512-NTF corresponds to the RESP18 homology domain (RESP18-HD) 368 
(32), which begins at amino acid residue 35, following the signal peptide and ends at a 369 
putative cleavage site for protein convertases, between residues 133 and 134 (17) (Fig. 370 
1A). Similar to RESP18 (32, 33), ICA512-RESP18-HD is characterized by a cysteine-371 
rich motif (Fig. 1A), which may be relevant for sorting into SGs. In particular, other 372 
characteristic neuroendocrine proteins, such as Chromogranin B and Secretogranin II, 373 
have been shown to depend on disulfide-bonded loops for their targeting to SGs (34-36). 374 
Consistent with the enrichment of RESP18 in SGs (32, 33), also soluble ICA512-375 
RESP18-HD-GFP co-localized extensively with insulin in SG like structures (Fig. 7A) 376 
and its recovery in the media was enhanced upon stimulation of the cells (Fig. 7B). 377 
Conversely, soluble ICA512-NTF-GFP, despite the inclusion of the RESP18-HD, rather 378 
displayed a diffuse ER like pattern (Figs. 7C and D), resembling that of the ER marker 379 
calnexin (Fig. 7D). A similar expression pattern was observed for ICA512-NTF (Fig. 7F), 380 
as detected with a novel antibody that recognizes human NTF, but not the equivalent 381 
domain of the endogenous rat protein (Fig. 7E, lane 1 vs. 2). These data exclude the 382 
possibility that retention of soluble ICA512-NTF in the ER is secondary to its misfolding 383 
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upon fusion with GFP. Intriguingly, in cells expressing soluble ICA512-NTF-GFP insulin 384 
immunoreactivity was also more diffuse, rather than being enriched in SGs, as in cells 385 
expressing ICA512-RESP18-HD-GFP (Fig. 7A). Thus, RESP18-HD contains 386 
information that is sufficient for SG targeting, while the remaining portion of ICA512-387 
NTF exerts a dominant role in ER retention, unless associated with the remaining C-388 
terminal transmembrane portion of the protein. 389 
 The ME ICA512 β4-β4 strand interface is involved in dimerization. Finally, we 390 
investigated in cells the occurrence of the main dimerization modes identified in the X-391 
ray structure of non-glycosylated ME ICA512 (18, 19). The association through a β2-β2 392 
interface was tested by the S508A mutation, which impedes dimerization in vitro (albeit 393 
not in the crystal) of recombinant non-glycosylated ME ICA512. The second 394 
dimerization mode, through the β4-β4 interface, was tested by the G553D replacement, 395 
which is sterically incompatible with it (19). ICA512-HA and ME ICA512-GFP variants 396 
with the symmetric single or combined mutations were co-expressed in INS-1 cells, and 397 
the lysates of the stimulated cells and the corresponding immunoprecipitates were 398 
analyzed by immunoblotting (Fig. 8A and 8B). While symmetric replacement of S508 399 
did not preclude the recovery of proICA512-HA S508A with ME ICA512-GFP S508A 400 
(Fig. 8B, lane 9), the symmetric replacement of G553 prevented the co-401 
immunoprecipitation of proICA512-HA G553D with ME ICA512-GFP G553D (Fig. 8C, 402 
lane 10). The recovery of proICA512-HA mutants with the corresponding ME ICA512-403 
GFP variants was specific, as co-immunoprecipitations with control IgG were 404 
significantly less effective compared to those with the anti-GFP antibody (Fig. 8B, lanes 405 
13-18 and Fig. 8C). These findings suggest that dimerization of proICA512 occurs 406 
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through β4-β4 interactions. Remarkably, however, the combined replacement of 407 
S508A/G553D was still permissive for ME ICA512 dimerization, albeit the recovered 408 
proICA512-HA S508A/G553D displayed a faster electrophoretic mobility (Fig. 8B, lane 409 
11), consistent with lack of N506 glycosylation.  Hence, even upon perturbation of the 410 
β4-β4 interface, the dimerization may still occur via the β2-β2 interaction, but only in 411 
conditions which prevent/precede N506 glycosylation. Glycosylation, because of its 412 
bulkiness, would impede the physical contact between β2-strands. Consistent with this 413 
interpretation was the greater yield of co-immunoprecipitated proICA512-HA upon 414 
replacement N506 rather than S508 in combination with G553 (Fig. 8B, lane 12 415 
and Fig. 8C).  416 
 According to the structural data N506 is less critical than S508 for the 417 
establishment/retention of β2-β2 dimer interface (19), and thus for protein folding and 418 
stability, as corroborated by the greater amount of proICA512-HA N506A/G553D 419 
compared to proICA512-HA S508A/G553D in the cell lysate (Fig. 8A, lane 6 vs. 5). 420 
Notably, β2-β2 proICA512 dimers are mainly retained in the ER, as shown in the specific 421 
case of proICA512-HA S508A/G553D, which for the most part remains Endoglycosidase 422 
H sensitive (Fig. 8D, lower panel) and is not converted into the corresponding mature 423 
ICA512-TMF species (Fig. 8D, upper panel). Hence, preclusion of N506 glycosylation 424 
does not rescue the replacement of G553, but it allows the detection of β2-β2 mediated 425 
dimerization of ME ICA512, which in normal conditions may only represent a transient 426 
state of the receptor. Once N506 glycosylation occurs, folding of the β4-β4 interface 427 
would become critical for stabilization/dimerization of proICA512 and for overcoming 428 
the dominant ER retention signal within ICA512-NTF, thus enabling the further 429 
Dimerization of proICA512/IA-2 ectodomain in the ER 
 21
progression of the protein along the secretory pathway and its RESP18-HD mediated 430 
targeting to the SGs (Fig. 8E). 431 
432 




Dimerization of RPTPs has been generally found to occur at the cell surface. This process 435 
is driven by the interaction of ligands to the extracellular domain and can affect the 436 
phosphatase activity of the cytoplasmic PTP domain. In the case of ICA512, however, no 437 
extracellular ligands have yet been identified. Its signaling pathway remains also unclear, 438 
albeit the calpain cleaved cytosolic fragment generated upon granule exocytosis has been 439 
suggested to act as a retrograde signal to modulate insulin SG mobility and biogenesis in 440 
relationship to the size and consumption of the SG stores (30, 23, 16).  In this work we 441 
have began to unravel some of the functional properties of the ICA512 SG luminal/ 442 
extracellular region. 443 
Specifically, we show that ME ICA512 is sufficient to promote ICA512 dimerization 444 
in cells (Fig. 2D), as suggested by previous structural studies of the corresponding 445 
recombinant portion of the receptor (18, 19). Notably, we only detected dimers of 446 
proICA512, but not of ICA512-TMF (Fig. 2C and D), implying that maturation of the 447 
protein resolves this interaction such that in the SGs ICA512-TMF is present as a 448 
monomer. On the other hand we cannot exclude that in the granule lumen ICA512-TMF 449 
forms instead a heterodimer with soluble ICA512-NTF generated from convertase-450 
mediated cleavage of proICA512 between residues 448 and 449 (Fig. 1A). Repeated 451 
attempts to co-immunoprecipitate ICA512-NTF with ICA512-TMF, however, have been 452 
unsuccessful. Since ICA512-NTF contains two additional likely sites for convertase 453 
cleavage between residues 133-134 and 387-388 (Fig. 1A), it is also possible that two 454 
putative fragments of ~28 kDa and ~7 kDa resulting from these cleavages might have not 455 
Dimerization of proICA512/IA-2 ectodomain in the ER 
 23
been detected on SDS-PAGE and Coomassie blue/silver staining, either being masked by 456 
the IgG light chain or due to their small size. Other factors that may disrupt ME ICA512 457 
dimers include post-translational modifications occurring while the protein transits from 458 
the ER to the SGs, the progressive intraluminal acidification of the Golgi and SG 459 
compartment and/or binding to other secretory proteins. Intriguingly, it has been reported 460 
that phogrin/IA-2β interacts with carboxypeptidase E/H (37). Finally, we cannot rule out 461 
that ME ICA512 prompts again homodimerization of ICA512-TMF once the latter is 462 
transiently inserted into the plasma membrane upon granule exocytosis. 463 
Our data suggest that dimerization of proICA512 occurs in the ER. Supporting this 464 
conclusion is the fact that proICA512-GFP G553D accumulates in the ER (Fig. 4D) and 465 
does not undergo O-glycosylation (Fig. 5B), a post-translation modification that most 466 
commonly occurs in the Golgi. However, ICA512-GFP ΔNTF G553D is 467 
Endoglycosidase H resistant and O-glycosylated (Fig. 5F). These findings together with 468 
the evidence that soluble NTF accumulates instead in the ER (Fig. 7C, 7D and 7F), 469 
suggest that NTF contains an ER retention signal. In contrast, soluble RESP18-HD-GFP, 470 
similar to its paralogue RESP18 (32, 33, 38) is targeted to the SGs (Fig. 7A) and released 471 
in a regulated fashion from the cells (Fig. 7B). Accordingly, ICA512-GFP ΔNTF is 472 
neither retained in the ER nor targeted to SGs, but constitutively delivered to the cell 473 
surface (Fig. 6A-C). Intriguingly, in cells overexpressing soluble NTF, but not soluble 474 
RESP18-HD, insulin immunoreactivity is also more diffused and less granular (Fig. 7C). 475 
Additional studies on the structure of ICA512-NTF and RESP18-HD and their roles in 476 
SG biogenesis will be necessary to elucidate the reason for these phenomena.  477 
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Extending previous findings (17, 39, 40), we show that N506 and N524 of ICA512 478 
are both glycosylated (Fig. 3A and 3B). Lack of glycosylation at these sites does not 479 
prevent targeting of proICA512 to SGs (Fig. 3D) and its conversion to ICA512-TMF 480 
(Fig. 3A). Simultaneous inhibition of N506 glycosylation and perturbation of the ME 481 
ICA512 β2-β2 association interface by replacement of S508A is also insufficient to 482 
prevent proICA512 conversion to ICA512-TMF (Fig. 3A) and ME ICA512 mediated 483 
homodimerization (Fig. 8B). Conversely, perturbation of the ME ICA512 β4-strand by 484 
G553D replacement hinders the stability, SG targeting and conversion of proICA512 485 
(Fig. 4A-D), as well as its recovery as a homodimer (Fig. 8B). On the other hand, 486 
combined S508A/G553D or N506A/G553D replacements are still compatible with 487 
proICA512 dimerization (Fig. 8B). A possible explanation for the latter finding is that the 488 
extended β2-β2 association interface (19, Fig. 1A and 1B) is sufficient for stable 489 
proICA512 dimerization, provided that glycosylation of N506, as upon S508A 490 
replacement, is precluded. This conclusion is corroborated by the greater yield of pro-491 
ICA512 homodimer recovered when the G553D mutation is combined with N506A 492 
replacement, which structural studies predict to be less detrimental for ME ICA512 β2-493 
β2 mediated dimerization than S508A replacement (Fig. 8B and 8C). Notably, such β2-494 
β2 mediated proICA512 dimers are restricted to the ER, as indicated by the 495 
Endoglycosidase H sensitivity and lack of conversion of proICA512-GFP S508A/G553D 496 
(Fig. 8D).  497 
In conclusion, we propose a model whereby proICA512 β2-β2 dimers prevail over 498 
β4-β4 dimers in the ER as long as the β2-strand N506 is not glycosylated possibly due to 499 
occlusion of this region by NTF. Dislocation of NTF, as upon its binding to another 500 
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molecule, would allow for N506 glycosylation, thus irreversibly shifting the equilibrium 501 
towards proICA512 β4-β4 dimers, consequently allowing ICA512 to leave the ER (Fig. 502 
8E). Importantly, this model does not assume that β4-β4 dimerization is per se the signal 503 
for ER export. Indeed, ICA512-GFP ΔNTF G553D, in which concomitant glycosylation 504 
of N506 and G553D replacement should hinder with the formation of both ME ICA512 505 
β2-β2 and β4-β4 dimers, is nevertheless exported from the ER, conceivably as a 506 
monomer. Hence, it is plausible that folding and/or homodimerization of ME ICA512 β4-507 
strand are instrumental to stabilize proICA512 and overcome the NTF ER retention 508 
signal. 509 
510 
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FIGURE LEGENDS 702 
 703 
FIG 1 Sequence of the ICA512 extracellular domain and model of ME ICA512 704 
dimerization through β2-β2 and β4-β4 interfaces. (A) Primary amino acid sequence of 705 
human ICA512 extracellular domain (amino acid residues 1-575), including the signal 706 
peptide (SP, residues 1-34), the RESP18 homology domain (RESP18-HD, residues 35-707 
133), as a part of the N-terminal fragment (NTF, residues 35-448) and the mature 708 
ectodomain (ME, residues 449-575, in bold). Residues in α-helices and β-strands of ME 709 
ICA512, as resolved in (18) are highlighted in orange and yellow, respectively. The N-710 
glycosylation sites N506 and N524 are indicated in red and cleavage sites for protein 711 
convertases (KR 132-133, KK 386-387 and KK 447-448) are underlined. Clustered 712 
cysteines within the RESP18-HD (C40, C47, C53 and C62) are indicated in italics, while 713 
threonines and serines predicted as putative O-glycosylation sites are indicated with 714 
asterisks. Critical residues for β2-β2 (S508) or β4-β4 (G553) mediated dimerization of 715 
recombinant ME ICA512 in vitro are shown in purple. (B) Modeled β2-β2 (left) or β4-β4 716 
(right) ME ICA512 dimers (the symmetry axes shown by dotted lines), as resolved by X-717 
ray crystallography (18). Color code for the relevant residues and secondary structures 718 
are as described in (A). Schematic drawing of ICA512 below shows the extracellular 719 
domain regions as in (A), followed by the transmembrane (TM) region and the cytosolic 720 
PTP domain. The arrow and arrowhead indicate the cleavage site for conversion of 721 
proICA512 into ICA512-TMF and the more distal cleavage site for calpain in the 722 
cytoplasmic domain of ICA512-TMF, respectively. 723 
 724 
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FIG 2 ME ICA512 is sufficient for dimerization of proICA512 in INS-1 cells. (A) 725 
Schematic drawing of ICA512-GFP and ICA512-HA, and their detection by 726 
immunoblotting with the mouse anti-GFP or rabbit anti-HA antibody in lysates of single 727 
transfected INS-1 cells. The arrows indicate the cleavage site for conversion of 728 
proICA512 into ICA512-TMF, while the arrowheads indicate the more distal calpain 729 
cleavage site in the cytoplasmic domain of ICA512-TMF. Prior to lysis cells were kept 730 
either at rest (R) in 0 mM glucose and 5 mM KCl or stimulated (S) for 2 hours either with 731 
55 mM KCl (High K+) or 25 mM glucose (High Glucose) or both (High Glucose and 732 
High K+, HGHK) (n≥3). (B) Immunoblottings for HA or GFP on lysates of INS-1 cells 733 
transfected with ICA512-HA alone or together with ICA512-GFP. Prior to lysis the cells 734 
were either kept at rest (R) or stimulated (S) for 2 hours with HGHK (n≥3). For 735 
normalization, the same cell lysates were also immunoblotted for γ-tubulin. (C) 736 
Immunoblottings for HA or GFP on immunoprecipitates with goat anti-GFP antibody or 737 
goat IgG from the lysates shown in (B) (n≥3). (D) Schematic drawing of ME ICA512-738 
GFP and immunoblottings for HA or GFP on lysates and corresponding 739 
immunoprecipitates with goat anti-GFP antibody from INS-1 cells transfected with 740 
ICA512-HA alone or together with ME ICA512-GFP. Prior to lysis the cells were kept at 741 
rest (R) or stimulated (S) for 2 hours with HGHK (n≥3). For normalization, the same cell 742 
lysates were also immunoblotted for γ-tubulin. 743 
 744 
FIG 3 Perturbing N-glycosylation or ME ICA512 β2-strand does not prevent ICA512 745 
targeting to SGs. (A, B) Immunoblottings for GFP or ICA512 on lysates of resting (A) or 746 
stimulated (B) INS-1 cells transfected either with ICA512-GFP wt or the mutants N506A, 747 
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N524A, N506A/N524A or S508A (n≥3). For normalization, the same cell lysates were 748 
also immunoblotted for γ-tubulin. (C) Quantification by ANOVA of proICA512-GFP 749 
species (top panel) and of the ratios of the corresponding proICA512-GFP/ICA512-TMF-750 
GFP species (bottom panel). Values ± SEM for each ICA512 species were normalized to 751 
those of γ-tubulin in the same lysates; *, p<0.005 (n=3). (D) Confocal microscopy images 752 
of HGHK stimulated INS-1 cells transfected with ICA512-GFP or the corresponding 753 
N506A/N524A or S508A mutants (in green) and immunostained for insulin (in red) 754 
(n≥3). Nuclei were labeled with DAPI (in blue). Scale bars = 5 μm. (E) Levels of insulin 755 
mRNA in ICA512-GFP wt and ICA512-GFP N506A/N524A sorted cells as measured by 756 
RT-PCR and normalized for β-actin mRNA levels (n=3). Levels of (F) proinsulin and (G) 757 
insulin content in ICA512-GFP wt and ICA512-GFP N506A/N524A sorted cells kept at 758 
rest (R) or stimulated (S) for 2 hours with HGHK as measured by ELISA (n=3). (H) 759 
Insulin secretion measured from ICA512-GFP wt and ICA512-GFP N506A/N524A 760 
sorted cells kept at rest (R) or stimulated (S) for 2 hours with HGHK (n=3).             761 
 762 
FIG 4 Perturbing the ME ICA512 β4-strand impairs proICA512 stability and targeting to 763 
SGs. (A, B) Immunoblottings for GFP on lysates of resting (R) or HGHK stimulated (S) 764 
INS-1 cells transfected with ICA512-GFP or ICA512-GFP G553D and untreated (-) or 765 
treated (+) with the protease inhibitors MG-115 (A) or calpeptin (B) (n≥3). For 766 
normalization, the same cell lysates were also immunoblotted for γ-tubulin. (C) 767 
Immunoblotting for GFP on lysates of HGHK stimulated INS-1 cells transfected with 768 
ICA512-GFP or ICA512-GFP G553D and untreated (-) or treated (+) with N-glycosidase 769 
PNGaseF (n≥3). (D) Confocal microscopy images of HGHK stimulated INS-1 cells 770 
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transfected with ICA512-GFP (top panels) or the corresponding G553D mutant (bottom 771 
panels), and immunostained for insulin (in red, left panels) or co-labeled with the ER 772 
tracker red (in red, right panels) (n≥3). Nuclei were labeled with DAPI (in blue). Scale 773 
bars = 5 μm. 774 
 775 
FIG 5 ME ICA512 is O-glycosylated. (A) Ponceau S staining of recombinant fetuin 776 
untreated (-) or treated (+) with O-glycosidases. (B) Immunoblottings for GFP on lysates 777 
of resting (R) or HGHK stimulated (S) INS-1 cells transfected with ICA512-GFP, 778 
ICA512-GFP N506A, ICA512-GFP S508A or ICA512-GFP G553D, untreated (-) or 779 
treated (+) with O-glycosidases (n≥3). (C) Immunoblotting for ICA512 on lysates of 780 
resting (R) or HGHK stimulated (S) mouse and human pancreatic islets, untreated (-) or 781 
treated (+) with O-glycosidases (upper and lower panels, n=3 and n=2, respectively). For 782 
normalization, the same lysates were also immunoblotted for γ-tubulin. (D) 783 
Immunoblottings for GFP on lysates of HGHK stimulated INS-1 cells transfected with 784 
ME ICA512-GFP, ME ICA512-GFP S508A or ME ICA512-GFP G553D, untreated (-) 785 
or treated (+) with O-glycosidases, PNGaseF or Endoglycosidase H (n=3). (E) Merge 786 
confocal microscopy images of INS-1 cells transfected with ME ICA512-GFP or ME 787 
ICA512-GFP G553D (in green) and co-labeled with the ER tracker red (in red) and DAPI 788 
for nuclei (in blue) (n=3). Scale bars = 10 μm. (F) Schematic drawing of ICA512-GFP 789 
ΔNTF, and immunoblotting for GFP on lysates of HGHK stimulated INS-1 cells 790 
transfected with ICA512-GFP ΔNTF, ICA512-GFP ΔNTF S508A or ICA512-GFP ΔNTF 791 
G553D, untreated (-) or treated (+) with O-glycosidases, PNGaseF or Endoglycosidase H 792 
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(n=3). Fetuin (A) and the ICA512 related protein fragments (B, C, F) sensitive to O-793 
glycosidase treatment (+) are indicated by arrowheads (<). 794 
 795 
FIG 6 NTF targets ICA512 to SGs. (A-C) Confocal microscopy images of resting (A, B) 796 
or HGHK stimulated (C) INS-1 cells transfected with ICA512-GFP (top panels, green) or 797 
ICA512-GFP ΔNTF (bottom panels, green). Live cells were incubated at 4 °C with the 798 
mouse anti-ME ICA512 antibody (A, C) together with the guinea pig anti-insulin 799 
antibody (A), and also alternatively with the mouse anti-ICA512 CT antibody (B). After 800 
fixation, the binding of the primary antibodies to the cell surface was detected by 801 
incubation with Alexa-conjugated anti-mouse (A, B, C; in red) or anti-guinea pig (A; in 802 
white) IgGs. Merge images are additionally shown for (A) and (C). Scale bars = 10 μm 803 
(n≥3). (D, E) Immunoblottings for GFP (D) and ME ICA512 (E) on lysates of resting (R) 804 
or HGHK stimulated (S) INS-1 cells transfected with ICA512-GFP or ICA512-GFP 805 
ΔNTF (n≥3). For normalization, the same lysates were also immunoblotted for γ-tubulin. 806 
 807 
FIG 7 NTF contains information for both ER retention and SG targeting. (A) Schematic 808 
drawing of ICA512-RESP18-HD-GFP, and confocal microscopy images of resting INS-1 809 
cells transfected with ICA512-RESP18-HD-GFP (in green) and immunostained for 810 
insulin (in red) (n≥3). Nuclei were labeled with DAPI (in blue). Scale bars = 5 μm. (B) 811 
Immunoblottings for GFP on lysates (left panel) or immunoprecipitates obtained with a 812 
different, goat anti-GFP antibody from incubation media (right panel) of resting (R) and 813 
HGHK stimulated (S) INS-1 cells transfected with ICA512-RESP18-HD-GFP (n≥3). The 814 
cell lysates were immunoblotted also for γ-tubulin. (C, D) Schematic drawing of ICA512-815 
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NTF-GFP, and confocal microscopy images of resting INS-1 cells transfected with 816 
ICA512-NTF-GFP (in green), and immunostained for insulin (C, in red) or calnexin (D, 817 
in red) (n≥3). Nuclei were labeled with DAPI (in blue). Scale bars = 5 μm. (E) 818 
Immunoblottings for GFP (left panel) or NTF (right panel), on lysates of INS-1 cells 819 
transfected with either CD33-GFP or ICA512-NTF-GFP (lanes 1 vs. 2) (n≥3). (F) 820 
Schematic drawing of ICA512-NTF, and confocal microscopy images of INS-1 cells 821 
transfected with ICA512-NTF, and immunostained for NTF (in green) and calnexin (in 822 
red) (n≥3). Scale bars = 5 μm. 823 
 824 
FIG 8 Establishment of ME ICA512 β4-β4 dimers overcome the NTF ER retention 825 
signal. (A) Immunoblottings for GFP (top panel) or HA (bottom panel) in the lysates of 826 
HGHK stimulated INS-1 cells transfected with ICA512-ΗΑ alone (lane 1) or double 827 
transfected with ICA512-HA and ME ICA512-GFP (lane 2) or with the respective 828 
ICA512-HA and ME ICA512-GFP mutants S508A, G553D, S508A/G553D or 829 
N506A/G553D (lanes 3-6) (n≥3). (B) Immunoblottings for GFP (top panel) or HA 830 
(bottom panel) on immunoprecipitates obtained with goat anti-GFP antibody (lanes 7-12) 831 
or control IgG (lanes 13-18) from the corresponding cell lysates shown in (B) (n≥3). (C) 832 
Quantification of the immunoprecipitates in (B), for all comparisons (n=5), p<0.05, *. 833 
(D) Immunoblottings for HA on Endoglycosidase H or PNGaseF untreated (-) or treated 834 
(+) lysates from resting (top panel) or HGHK stimulated (bottom panel) INS-1 cells 835 
transfected with ICA512-HA, ICA512-HA S508A, G553D or S508A/G553D (n≥3). (E) 836 
Model on how N506 glycosylation affects the folding and dimerization of ME ICA512 837 
β2-β2 and β4-β4 association interfaces and the export of proICA512 from the ER. 838 








